Kraig Biocraft confirms commercial spider silk success.

Kraig Biocraft Laboratories announced a major milestone in its commercialization efforts. Rigorous testing has confirmed its commercially produced recombinant spider silk maintains the exceptional strength and toughness demonstrated in previous lab trials.

This breakthrough validates the company's production process and paves the way for fast scaling up of its proprietary spider silk. The material's superior performance compared to traditional silk is expected to open up new opportunities in various industries. Kraig Labs COO, Jon Rice, is excited about scaling up production and introducing this innovative material to the market.